Results Highlights:
§ Total revenue was HK$ 726.9 million, decreased by 2.9% YoY
§ Profit attributable to shareholders was HK$31.44 million, reduced by HK$ 9.2 million or 22.6% YoY
§ EBITDA was HK$87.03 million, increase by 2.7% YoY. Excluding goodwill and investment impairment as well as one-off gains, core business EBITDA ("Adjusted EBITDA") was approximately HK$94.88 million, increased by 21.1%. The significant increase in EBITDA was mainly due to improved operational efficiency and reduction in various operating costs
§ Basic earnings per share were HK$3.98 cents
§ Cash Balance was HK$303 million, increased by 18.2% YoY
§ The Board proposed a final dividend of HK1.9 cents per share, representing a HK3.3 cents annualized dividend, payout ratio of about 85%
UMP Healthcare Holdings Limited (“UMP” or the “Group”, Stock Code: 722.HK) announced its audited consolidated annual results for the financial year ended 30 June 2025 (the “FY2025”). Over the past year, the Group has successfully reduced costs and increased efficiency through corporate transformation and strategic resilience building. Core business EBITDA ("Adjusted EBITDA") increased significantly by 21.1% year-on-year to approximately HK$94.88 million, while cash holdings also grew significantly by nearly 20%. The Board proposed paying a final dividend of HK1.9 cents per share, bringing the full-year dividend to HK3.3 cents (FY2024: HK3.3 cents), with a payout ratio of approximately 85%, substantially higher than last year's 65.9%, rewarding shareholders.
During the reporting period, the annual profit attributable to shareholders was HK$31.44 million, with a return on equity of 4.2% and basic earnings per share of HK3.98 cents. The Group's cash on hand increased by 18.2% year-on-year to approximately HK$303 million, while the gearing ratio remained at an extremely low level of 7.1% (FY2024: 7%), giving the Group confidence to face a series of future risks and challenges, with sufficient resources to prepare for investment opportunities.
2025 marks the Group's 35th anniversary, as well as its 10th anniversary as a listed company, at this significant milestone, the Group has thoroughly revamped its brand image, reevaluated each department's responsibilities and processes, and eliminated existing barriers to foster more seamless communication and collaboration between teams. The Group has dramatically improved operational efficiency by eliminating unnecessary processes, reducing resource waste, and optimized human resource arrangements. These changes have led to significant reductions in costs for staff, medical supplies, rent, and facility maintenance, substantially enhancing the profitability of its business operations.
The Group launched its new logo on 17 September, to present a more modern corporate image aligned with its future development. The new logo simplifies the original design while ensuring clarity and strategic consistency across the healthcare ecosystem. It embodies the company's commitment to honoring tradition while embracing innovation, symbolizing our ability to maintain vitality and forward thinking in a changing market, it represents innovation while maintaining stability, unconstrained by convention, also highlights the Group's alignment with the government in promoting preventive healthcare, advocating for disease screening, and emphasizing the principle of early detection and early treatment. This launch marks the beginning of a new era for the Group's brand, enabling customers and partners to experience the company's dynamic evolution.
Active Participation in Government Projects Drives Patient Flow
During the period, the Group actively participated in government tenders for outsourced healthcare and diagnostic services. This strategy helped diversify revenue sources, ensured higher utilization of advanced clinic equipment, and strengthened UMP's reputation as a trusted partner in public healthcare and preventive services. Additionally, the Group strategically adjusted its service positioning to benefit from the government's fiscal policy of increasing public hospital service charges. As these fees rose, the Group's services became more price-competitive for both private patients and corporate clients, making UMP medical centers a more attractive option and driving increased patient flow.
In line with the establishment of a chronic disease co-care platform proposed in the 2025 Policy Address, and to expand preventive screening and nursing services in family medicine clinics, promoting domestic healthcare management, UMP has developed and launched community-based health programs. These initiatives focus on promoting local district healthcare management, including health screenings, vaccination drives, and chronic disease education. This aligns with public policy objectives, and in addition to enhancing corporate social responsibility profile, and drives patient volume into the Group's ecosystem.
During the past fiscal year, the Group expanded profit margins by enhancing operational efficiency and leveraging economies of scale through third-party management platforms. These platform investments delivered multiple benefits: faster claims processing, lower administrative costs for corporate clients, and improved data analytics capabilities. This not only enhanced the member experience but also provided corporate and insurance partners with valuable insights into healthcare trends and cost drivers. These improvements represent a significant step toward comprehensive digitalization and seamless user experience.
To strengthen its competitive advantages and operational efficiency, the Group strategically leveraged the Greater Bay Area for back-office support. This approach taps into the region's cost-effectiveness and high-quality talent pool to support key functions including data processing, claims management, and customer service. The strategy not only reduced operating costs but also improved the scalability of the Group's services.
During the past fiscal year, UMP partnered with several major Mainland insurers to white-label or integrate its Third-Party Administrator services into their health insurance products. This expansion of the business-to-business-to-consumer (B2B2C) model provides insurers with advanced healthcare management solutions while enhancing the attractiveness of their product offerings.
Cost Improvement - Clinical Healthcare Services Profit Increased by 16%
During the reporting period, the Group's Clinical Healthcare Services in Hong Kong and Macau recorded a 4.3% decrease in revenue, but operating profit rose by 16.4 %, driven by corporate restructuring policies focused on cost reduction and efficiency enhancement, through operational excellence, cost improvement, and integration with government healthcare programs to ensure sustainable profitability. These efforts led to significant reductions in costs for staff, medical supplies, rent, and facility maintenance. The division achieved stable and profitable growth in the 2025 fiscal year, benefiting both from organic growth of existing centers and contributions from newly acquired or established facilities.
Looking ahead, the Group will align its development with healthcare integration policies in the Greater Bay Area and other cities in Mainland, facilitating easier access to Mainland medical services for Hong Kong based employees of Mainland enterprises through designated networks. The Group will continue to invest in digital platforms to streamline cross-border authorization and claims processes , enhancing both operational efficiency and user experience. The complementary nature of the Group's diversified product portfolio will continue to demonstrate the strategic value of its integrated business model.
Jacquen Kwok, Executive Director and Co-Chief Executive Officer of UMP said, "By understanding the ever-changing market demands and responding with innovative, efficient, and high-value solutions, the Group has developed a series of innovative technologies to provide greater convenience for customers and partners. UMP has consolidated its market leadership position. We are confident that continuing our current effective business model and clear strategic roadmap will lead us to create sustainable growth and value for all stakeholders in the 2026 fiscal year and beyond."
UMP's long-term strategy targets the Mainland China healthcare market, which is gradually becoming integral to the Group's diversification and growth plans. The expertise gained from this market directly informs and supports the development of UMP's cross-border third-party management services. While revenue from this emerging segment continues to grow, partnerships formed during fiscal year 2025 have established a solid foundation for future income. As these insurance products gain market acceptance, the segment is expected to generate high-margin revenue streams. UMP will continue building a comprehensive in-house clinic network to maintain control over service quality, enhance patient experience, and improve profitability.
Dr. Michael SUN, Vice Chairman and Co-CEO of UMP remains cautiously optimistic about the 2026 fiscal year, "While the economic environment continues to pose challenges, the fundamental demand for quality healthcare in Hong Kong remains strong. We will continue to utilize cost-effective operational models to protect profitability, maintain flexibility, and stay ready to capitalize on any market recovery or new demand opportunities. The Group will also launch a comprehensive member mobile application to facilitate more convenient services, remote consultations, and personalized health tracking. Additionally, UMP will actively explore opportunities to expand its service model in other key markets across the Asia-Pacific region and introduce new service lines."
Looking ahead, UMP remains committed to delivering high-quality clinical healthcare services while adapting to evolving market conditions. Continued investment in partnerships, technology, and regional expansion will be key pillars of growth and sustainability.